Volume Spike Investor

Human Genome Sciences Inc. (NASDAQ: HGSI) is trading higher this morning, and it doesn’t seem to be tied to those pesky buyout or merger rumors that were persisting for a couple of weeks.  The company announced that a medical journal published positive comments concerning its lupus drug candidate, which may be like reporting from the Department of Redundancy Department.  Shares are up 4% at $18.92 on almost 230,000 shares as of 9:08 AM EST.  Average volume is now 12.6 million shares, and this ‘news’ is not really news when you consider the news flow that has already come from the company. -JON OGG